Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Long-Term Capital Lease Obligation : ¥63 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Long-Term Capital Lease Obligation?

Jiangsu Hengrui Pharmaceuticals Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥63 Mil.

Jiangsu Hengrui Pharmaceuticals Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥51 Mil) to Dec. 2024 (¥69 Mil) but then declined from Dec. 2024 (¥69 Mil) to Mar. 2025 (¥63 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥99 Mil) to Dec. 2023 (¥75 Mil) and declined from Dec. 2023 (¥75 Mil) to Dec. 2024 (¥69 Mil).

Jiangsu Hengrui Pharmaceuticals Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Long-Term Capital Lease Obligation Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

151.59

98.86

75.18

69.04

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															78.40	58.28	51.31	69.04	62.71

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Jiangsu Hengrui Pharmaceuticals Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

01276:Hong Kong

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Executives

Zhang Lian Shan	Directors, senior managers
Sun Xu Gen	senior management
Yuan Kai Hong	senior management
Zou Jian Jun	senior management
	senior management
Zhang Yue Hong	senior management
Liu Xiao Han	senior management
Zhou Yun Shu	Directors, senior managers
Liao Cheng	senior management
Wang Hong Sen	senior management
Zhou Song	senior management
Tao Wei Kang	senior management
Jiang Su Mei	senior management
Dai Hong Bin	Directors, senior managers
Sun Jie Ping	Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co Headlines

No Headlines